George Golumbeski - Net Worth and Insider Trading
George Golumbeski Net Worth
The estimated net worth of George Golumbeski is at least $536,501 dollars as of 2024-05-16. George Golumbeski is the Director of Shattuck Labs Inc and owns about 54,613 shares of Shattuck Labs Inc (STTK) stock worth over $440,181. George Golumbeski is the Director of Sage Therapeutics Inc and owns about 8,000 shares of Sage Therapeutics Inc (SAGE) stock worth over $96,320. George Golumbeski is also the Director of Enanta Pharmaceuticals Inc and owns about 0 shares of Enanta Pharmaceuticals Inc (ENTA) stock worth over $0. Details can be seen in George Golumbeski's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that George Golumbeski has not made any transactions after 2022-05-05 and currently still holds the listed stock(s).
Transaction Summary of George Golumbeski
George Golumbeski Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, George Golumbeski owns 5 companies in total, including Shattuck Labs Inc (STTK) , Corbus Pharmaceuticals Holdings Inc (CRBP) , and Sage Therapeutics Inc (SAGE) among others .
Click here to see the complete history of George Golumbeski’s form 4 insider trades.
Insider Ownership Summary of George Golumbeski
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| STTK | Shattuck Labs Inc | 2022-04-26 | director |
| CRBP | Corbus Pharmaceuticals Holdings Inc | 2020-07-06 | director |
| SAGE | Sage Therapeutics Inc | 2022-05-05 | director |
 | | 2019-03-04 | director |
| | 2013-09-18 | director |
George Golumbeski Latest Holdings Summary
George Golumbeski currently owns a total of 3 stocks. Among these stocks, George Golumbeski owns 54,613 shares of Shattuck Labs Inc (STTK) as of April 26, 2022, with a value of $440,181 and a weighting of 82.05%. George Golumbeski owns 8,000 shares of Sage Therapeutics Inc (SAGE) as of May 5, 2022, with a value of $96,320 and a weighting of 17.95%. George Golumbeski also owns 0 shares of Enanta Pharmaceuticals Inc (ENTA) as of March 4, 2019, with a value of $0 and a weighting of 0%.
Latest Holdings of George Golumbeski
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| STTK | Shattuck Labs Inc | 2022-04-26 | 54,613 | 8.06 | 440,181 |
| SAGE | Sage Therapeutics Inc | 2022-05-05 | 8,000 | 12.04 | 96,320 |
| ENTA | Enanta Pharmaceuticals Inc | 2019-03-04 | 0 | 13.33 | 0 |
Holding Weightings of George Golumbeski
George Golumbeski Form 4 Trading Tracker
According to the SEC Form 4 filings, George Golumbeski has made a total of 2 transactions in Shattuck Labs Inc (STTK) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Shattuck Labs Inc is the acquisition of 28,330 shares on April 26, 2022, which cost George Golumbeski around $102,838.
According to the SEC Form 4 filings, George Golumbeski has made a total of 1 transactions in Sage Therapeutics Inc (SAGE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Sage Therapeutics Inc is the acquisition of 8,000 shares on May 5, 2022, which cost George Golumbeski around $251,600.
According to the SEC Form 4 filings, George Golumbeski has made a total of 0 transactions in Enanta Pharmaceuticals Inc (ENTA) over the past 5 years. The most-recent trade in Enanta Pharmaceuticals Inc is the sale of 9,280 shares on March 4, 2019, which brought George Golumbeski around $961,872.
Insider Trading History of George Golumbeski
- 1
George Golumbeski Trading Performance
GuruFocus tracks the stock performance after each of George Golumbeski's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by George Golumbeski is 21.72%. GuruFocus also compares George Golumbeski's trading performance to market benchmark return within the same time period. The performance of stocks bought by George Golumbeski within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how George Golumbeski's insider trading performs compared to the benchmark.
Performance of George Golumbeski
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -10.56 | | | | | |
| Relative Return to S&P 500(%) | -6.42 | | | | | |
George Golumbeski Ownership Network
George Golumbeski Owned Company Details
What does Shattuck Labs Inc do?
Who are the key executives at Shattuck Labs Inc?
George Golumbeski is the director of Shattuck Labs Inc. Other key executives at Shattuck Labs Inc include See Remarks Stephen Stout , See Remarks Andrew R Neill , and Chief Technical Officer Abhinav A. Shukla .
Shattuck Labs Inc (STTK) Insider Trades Summary
Over the past 18 months, George Golumbeski made no insider transaction in Shattuck Labs Inc (STTK). Other recent insider transactions involving Shattuck Labs Inc (STTK) include a net sale of 25,000 shares made by Andrew R Neill , and a net sale of 16,004 shares made by Stephen Stout .
In summary, during the past 3 months, insiders sold 16,004 shares of Shattuck Labs Inc (STTK) in total and bought 0 shares, with a net sale of 16,004 shares. During the past 18 months, 41,004 shares of Shattuck Labs Inc (STTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 41,004 shares.
Shattuck Labs Inc (STTK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Shattuck Labs Inc Insider Transactions
George Golumbeski Mailing Address
Above is the net worth, insider trading, and ownership report for George Golumbeski. You might contact George Golumbeski via mailing address: C/o Celgene Corp., 86 Morris Avenue, Summit Nj 07901.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
